(Q42988404)

12 November 2017

title

Is it possible to diagnose acute hepatitis C virus (HCV) infection by a rising anti-HCV titre rather than by seroconversion? (English)

1 reference

12 November 2017

1 reference

1 reference

Lu SN

1

1 reference

12 November 2017

Tung HD

2

1 reference

12 November 2017

Chen TM

3

1 reference

12 November 2017

Lee CM

4

1 reference

12 November 2017

Wang JH

5

1 reference

12 November 2017

Hung CH

6

1 reference

12 November 2017

Chen CH

7

1 reference

12 November 2017

Changchien CS

8

1 reference

12 November 2017

publication date

1 November 2004

1 reference

Journal of Viral Hepatitis

12 November 2017

published in

1 reference

12 November 2017

volume

11

1 reference

12 November 2017

issue

6

1 reference

12 November 2017

page(s)

563-570

1 reference

Performance of three generations of anti-hepatitis C virus enzyme-linked immunosorbent assays in donors and patients

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00533.X

Evaluation of newly developed microparticle enzyme immunoassays for the detection of HCV antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00533.X

Antiviral treatment responses in patients with chronic hepatitis C virus infection evaluated by a third generation anti-hepatitis C virus assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00533.X

Treatment of acute hepatitis C with interferon alfa-2b

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00533.X

Full or partial seroreversion in patients infected by hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00533.X

Spontaneous viral clearance in patients with acute hepatitis C can be predicted by repeated measurements of serum viral load

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00533.X

Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00533.X

Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00533.X

Long-term follow-up of anti-hepatitis C virus antibodies in patients with acute nonA nonB hepatitis and different outcome of liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00533.X

10.1111/J.1365-2893.2004.00533.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference